341
Participants
Start Date
July 5, 2017
Primary Completion Date
February 27, 2025
Study Completion Date
February 27, 2025
Nab-Paclitaxel
Nab-Paclitaxel will be administered as per the schedule specified in the respective arm.
Gemcitabine
Gemcitabine will be administered as per the schedule specified in the respective arm.
Oxaliplatin
Oxaliplatin will be administered as per the schedule specified in the respective arm.
Leucovorin
Leucovorin will be administered as per the schedule specified in the respective arm.
Fluorouracil
Fluorouracil will be administered as per the schedule specified in the respective arm.
Atezolizumab
Atezolizumab will be administered as per the schedule specified in the respective arm.
Cobimetinib
Cobimetinib will be administered as per the schedule specified in the respective arm.
PEGPH20
PEGPH20 will be administered as per the schedule specified in the respective arm.
BL-8040
BL-8040 will be administered as per the schedule specified in the respective arm.
Selicrelumab
Selicrelumab will be administered as per the schedule specified in the respective arm.
Bevacizumab
Bevacizumab will be administered as per the schedule specified in the respective arm.
RO6874281
RO6874281 will be administered as per the schedule specified in the respective arm
AB928
AB928 will be administered as per the schedule specified in the respective arm.
Tiragolumab
Tiragolumab will be administered as per the schedule specified in the respective arm.
Tocilizumab
Tocilizumab will be administered as per the schedule specified in the respective arm.
Columbia University, New York
Memorial Sloan Kettering Cancer Center, New York
Hillman Cancer Center, Pittsburgh
Lombardi Cancer Center, Georgetown University, Washington D.C.
Hosp. G. U Gregorio Marañón, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Clínica Universidad de Navarra, Pamplona
Universitätsklinikum Essen, Essen
Medical College of Wisconsin, Milwaukee
Uni of Chicago Medical Center, Chicago
City of Hope Comprehensive Cancer Center, Duarte
Helen Diller Fam Comp Can Ctr, San Francisco
Oregon Health and Science University, Portland
Smilow Cancer Hospital at Yale New Haven, New Haven
Dana-Farber Cancer Institute, Boston
MorristownMedicalCenter, Morristown
National Cancer Center Hospital East, Chiba
Kanagawa Cancer Center, Kanagawa
National Cancer Center Hospital, Tokyo
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitario Vall d Hebron, Barcelona
Hoffmann-La Roche
INDUSTRY